OVARIAN CARCINOMA is a serious problem to the gynaecologist. Annual deaths now exceed 3000 in England and Wales and 10,000 in the U.S.A. In England and Wales in the year 1968 it may be seen that deaths due to carcinoma of the ovary were second only to carcinoma of the breast (Table I) , and it is now the leading cause of death from gynaecological malignancy. The annual death rate is generally reported as eighteen per 100,000 of the population. It has been stated that about 30 women in 100,000 will develop ovarian cancer before the age of 45 years and that it increases to 281 per 100,000 between the ages of 45 to 60 years (Graber, 1969) . The disturbing feature is that due to lack of symptoms, ovarian carcinoma does not usually present until the disease has metastasized widely, when the results of any form of treatment are likely to be poor. The 5-year survival rates are disappointing, all stages in the U.S.A. being 10-2 per cent whilst in England (London Hospital 1960-64 (Graham and Von Niekerk, 1962) .
Thus, attempts at early diagnosis assume great importance and the most notable of these is culdocentesis (Keettel and Pixley, 1958; Graham et al., 1964; Graham and Graham, 1967; Grillo et al., 1966; McGowan et al., 1966; Zervakis et al., 1969 (Schiller, 1940; Woodruff and Novak, 1954) giving rise to cystic and solid poorlydifferentiated adenocarcinomata with the highest incidence in the 40 to 60 age group. Taylor (1959) points out the ability of germinal epithelium of the ovary to produce structures of epithelium lined clefts that eventually deepen sufficiently to form papillomas. The inference is that these structures may be the forerunners of papillary serous eystadenomas and cystadenocareinomas. It is of interest that the majority of ovarian carcinomas are of the papillary serous variety.
Of the ten ovarian carcinomas in our own series, from the surface of which smears were taken, neoplastic cells were detected in eight, the It is of interest to note that in this hospital, the age structure of patients
